FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

5 letters match. Newest first.

  1. TKTX USA

    FDA warned TKTX USA that its TKTX Numbing Creams are unapproved and misbranded drugs with lidocaine levels above OTC limits.

    High risk
  2. Centura Pharmaceuticals Inc

    FDA warned Centura Pharmaceuticals that its BLT 1-2-3 Cream, a mixed numbing product for cosmetic procedures, is an unapproved new drug.

    High risk
  3. Dermal Source, Inc.

    FDA warned Dermal Source that five topical anesthetic products are unapproved and misbranded drugs with lidocaine above OTC limits.

    High risk
  4. TKTX Company

    TKTX Company sells unapproved, misbranded lidocaine numbing creams online at illegal concentrations for cosmetic procedures.

    High risk
  5. Cetylite Industries, Inc.

    FDA warned Cetylite Industries over CGMP violations at its Pennsauken, NJ facility, including unvalidated testing and inadequate OOS investigations for topical anesthetics.

    High risk